skip to contentskip to secondary navigation
Getting to the centre 03 9496 5000
Make a difference
Donate
  • Patients & family
    • Becoming our patient
      • How to become an ONJ patient
      • Planning for your care
    • Diagnosis & Treatment
      • Cancer types
      • A new diagnosis
      • Cancer treatment
      • Your Wellness matters
      • Commonly asked questions
    • Clinical Haematology
      • Allogeneic stem cell transplant
      • Autologous stem cell transplant
    • Visitors
  • For health professionals
    • What we do
      • Cancer types & treatment
    • Referral
      • Referral for treatment
      • Referral to palliative care
    • Careers at Austin Health
  • Research
  • About
    • Maps & directions
    • A public hospital with a difference
    • Dame Olivia Newton-John
    • Contact us
  • Ways to help
    • Ways to help today
      • Leave a gift in your Will
      • USA Donations
      • Become a hero today
    • Get Involved
      • Attend an event
      • Corporate partnerships
      • Dry July
    • How your gift helps
      • Why I give
      • People you've helped
      • Impact Report
    • We'll be here for you...but we need your help
180315 ONJCRI PORTRAIT ANDREAS 0003

Dr Andreas Behren

Head, Tumour Immunology Laboratory

More about Dr Andreas Behren

Working closely with medical scientists in a translational setting allows us every day to challenge and re-evaluate our laboratory findings against the real world and to progress step-by-step towards improved cancer therapies.

After finishing my PhD in the area of viral induced head and neck cancers in Germany in 2006, and a short period of postdoctoral training in Heidelberg, Germany I was recruited in 2008 to the Ludwig Institute of Cancer Research. Here, I worked in the group of Prof. Cebon on various aspects of melanoma development and progression with a focus on EMT-like events, tumor cell invasion and resistance mechanisms. During this time we established several academic-industry collaborations which led to the recent filing of a patent for a novel antibody target in melanoma together with CSL Ltd.

My research focus is currently on understanding the biology of this target and gaining insights into the exact mechanisms of immune cell-cancer cross-talk and how these can be utilized for therapeutic approaches. In 2012, I was appointed a group leader in the laboratory of Prof. Cebon a position I am currently holding within the Olivia Newton-John Cancer Research Institute. In this role, I am supervising PhD/Master's students and provide guidance to Junior Postdoctoral Fellows.

Education

Diploma, Biology, Eberhard Karls University Tuebingen, Germany

PhD, University Hospital Tuebingen, Germany; DFG- Graduate Programme 686, Thesis: ‘Involvement of mitogen-activated protein kinases in development, invasion, and recurrence of squamous cell carcinomas of the head and neck in various model systems’

Current Appointments

Head, Tumour Immunology Laboratory, Olivia Newton-John Cancer Research Institute

Achievements

Member, Cure Cancer Research Consultative Committee, Cure Cancer Australia Foundation, 2014-ongoing

Young Investigator Postdoctoral Fellowship, Cure Cancer Australia Foundation, 2012-2014

 

Email: andreas.behren@onjcri.org.au

  • Home
  • Ways to help
  • Patients & family
  • For health professionals
  • Research
  • News
  • About
  • ONJ-events
  • Research
  • Collection notice
AustinHealth_Logo
 
Connect with us

Keep up to date with what’s happening at the ONJ Centre.

   

Call us

03 9496 5000

Calling from overseas

+613 9496 5000

Address

145 Studley Road (On the corner of Studley Rd and Bell St) Heidelberg, Victoria, Australia.